Organon Co Stock Fundamentals
| OGN Stock | USD 20.67 0.29 1.38% |
Organon Co fundamentals help investors to digest information that contributes to Organon's financial success or failures. It also enables traders to predict the movement of Organon Stock. The fundamental analysis module provides a way to measure Organon's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Organon stock.
At this time, Organon's Net Income is very stable compared to the past year. As of the 6th of June 2024, Depreciation And Amortization is likely to grow to about 373.9 M, while Tax Provision is likely to drop about 90.2 M. Organon | Select Account or Indicator |
Organon Co Company Return On Asset Analysis
Organon's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Organon Return On Asset | 0.0744 |
Most of Organon's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Organon Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Organon Total Assets
Total Assets |
|
Based on the latest financial disclosure, Organon Co has a Return On Asset of 0.0744. This is 100.85% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 153.14% lower than that of the firm.
Organon Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Organon's current stock value. Our valuation model uses many indicators to compare Organon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Organon competition to find correlations between indicators driving Organon's intrinsic value. More Info.Organon Co is regarded second in return on asset category among its peers. It is considered to be number one stock in profit margin category among its peers fabricating about 2.22 of Profit Margin per Return On Asset. At this time, Organon's Net Profit Margin is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organon's earnings, one of the primary drivers of an investment's value.Organon's Earnings Breakdown by Geography
Organon Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Organon's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Organon could also be used in its relative valuation, which is a method of valuing Organon by comparing valuation metrics of similar companies.Organon is currently under evaluation in return on asset category among its peers.
Organon ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Organon's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Organon's managers, analysts, and investors.Environmental | Governance | Social |
Organon Fundamentals
| Return On Asset | 0.0744 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 13.51 B | ||||
| Shares Outstanding | 257.17 M | ||||
| Shares Owned By Insiders | 0.15 % | ||||
| Shares Owned By Institutions | 79.71 % | ||||
| Number Of Shares Shorted | 8.11 M | ||||
| Price To Earning | 4.20 X | ||||
| Price To Book | 1.84 X | ||||
| Price To Sales | 0.71 X | ||||
| Revenue | 6.26 B | ||||
| Gross Profit | 3.89 B | ||||
| EBITDA | 1.55 B | ||||
| Net Income | 1.02 B | ||||
| Cash And Equivalents | 706 M | ||||
| Cash Per Share | 2.14 X | ||||
| Total Debt | 8.76 B | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.19 X | ||||
| Cash Flow From Operations | 799 M | ||||
| Short Ratio | 3.37 X | ||||
| Earnings Per Share | 4.08 X | ||||
| Price To Earnings To Growth | (1.75) X | ||||
| Target Price | 22.5 | ||||
| Number Of Employees | 10 K | ||||
| Beta | 0.77 | ||||
| Market Capitalization | 5.4 B | ||||
| Total Asset | 12.06 B | ||||
| Retained Earnings | 443 M | ||||
| Working Capital | 1.59 B | ||||
| Annual Yield | 0.05 % | ||||
| Net Asset | 12.06 B | ||||
| Last Dividend Paid | 1.12 |
About Organon Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Organon Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organon Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 206 M | 216.3 M | |
| Total Revenue | 6.3 B | 6.3 B | |
| Cost Of Revenue | 2.5 B | 2.5 B | |
| Stock Based Compensation To Revenue | 0.02 | 0.02 | |
| Sales General And Administrative To Revenue | 0.27 | 0.17 | |
| Research And Ddevelopement To Revenue | 0.09 | 0.04 | |
| Capex To Revenue | (0.04) | (0.04) | |
| Revenue Per Share | 24.54 | 32.08 | |
| Ebit Per Revenue | 0.21 | 0.34 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Organon Stock
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:Check out Organon Piotroski F Score and Organon Altman Z Score analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.13 | Dividend Share 1.12 | Earnings Share 4.08 | Revenue Per Share 24.835 | Quarterly Revenue Growth 0.055 |
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.